Abstract
Background
Monitoring respiratory rate (RR) is recommended at the time of hospital presentation for acute decompensation in heart failure (HF). Device-based continuous monitoring of RR may be helpful for diagnostic and prognostic stratification after implantable cardioverter-defibrillator (ICD) implantation. This study was undertaken to analyze short- and long-term changes in ICD-measured RR and to relate RR with the patient’s clinical status and the occurrence of HF events.
Methods
One hundred twenty-four consecutive HF patients who received ICD endowed with this diagnostic capability (Boston Scientific Inc., Natick, MA, USA) were prospectively enrolled. Patients were followed up for 12 months.
Results
At the baseline, the proportion of New York Heart Association (NYHA) class III–IV was higher among patients with daily maximum RR >27 breaths/min (third tertile) than those with <24 breaths/min (first tertile) (43 vs. 23 %, p < 0.05). Moreover, the ejection fraction was lower (27 ± 7 vs. 34 ± 8 %, p < 0.05). In patients with HF hospitalizations (33 events) and urgent visits for HF (15 events), the weekly average of RR calculated over the 7 days preceding hospital accesses did not differ from values recorded at the baseline and before scheduled follow-up visits. However, the weekly variation in RR (i.e., the difference between maximum and minimum values collected over the week) was significantly higher prior to hospitalization (p < 0.05). A weekly variation >3 breaths/min in maximum RR predicted an impending hospital admission for HF with sensitivity of 73 % and specificity of 57 %.
Conclusions
In this study, elevated values of ICD-monitored RR identified patients with worse functional status and lower systolic function. The weekly variation in RR increased before HF exacerbation. This monitoring technology may represent a useful tool in the clinical management of patients with HF.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10840-015-0007-3/MediaObjects/10840_2015_7_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10840-015-0007-3/MediaObjects/10840_2015_7_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10840-015-0007-3/MediaObjects/10840_2015_7_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10840-015-0007-3/MediaObjects/10840_2015_7_Fig4_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10840-015-0007-3/MediaObjects/10840_2015_7_Fig5_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10840-015-0007-3/MediaObjects/10840_2015_7_Fig6_HTML.gif)
Similar content being viewed by others
Abbreviations
- CRT-D:
-
Cardiac resynchronization therapy defibrillators
- ICD:
-
Implantable cardioverter-defibrillators
- HF:
-
Heart failure
- RR:
-
Respiratory rate
References
Cleland, J. G., Daubert, J. C., Erdmann, E., Freemantle, N., Gras, D., Kappenberger, L., Tavazzi, L., & Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352, 1539–1549.
McMurray, J. J., Adamopoulos, S., Anker, S. D., et al. (2012). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal, 33, 1787–1847.
Kadhiresan, V. A., Pastore, J., Auricchio, A., Sack, S., Doelger, A., Girouard, S., Spinelli, J. C., & PATH-CHF Study Group. (2002). Pacing therapies in congestive heart failure: a novel method—the activity log index—for monitoring physical activity of patients with heart failure. American Journal of Cardiology, 89, 1435–1437.
Conraads, V. M., Spruit, M. A., Braunschweig, F., Cowie, M. R., Tavazzi, L., Borggrefe, M., Hill, M. R., Jacobs, S., Gerritse, B., & van Veldhuisen, D. J. (2014). Physical activity measured with implanted devices predicts patient outcome in chronic heart failure. Circulation. Heart Failure, 7, 279–287.
Landolina, M., Gasparini, M., Lunati, M., et al. (2008). Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure. European Journal of Heart Failure, 10, 1073–1079.
Santini, M., Gasparini, M., Landolina, M., et al. (2011). Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. Journal of the American College of Cardiology, 57, 167–172.
Conraads, V. M., Tavazzi, L., Santini, M., Oliva, F., Gerritse, B., Yu, C. M., & Cowie, M. R. (2011). Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. European Heart Journal, 32, 2266–2273.
van Veldhuisen, D. J., Braunschweig, F., Conraads, V., et al. (2011). Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation, 124, 1719–1726.
Forleo, G. B., Tesauro, M., Panattoni, G., et al. (2012). Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes. Heart, 98, 402–407.
Page, E., Cazeau, S., Ritter, P., Galley, D., & Casset, C. (2007). Physiological approach to monitor patients in congestive heart failure: application of a new implantable device-based system to monitor daily life activity and ventilation. Europace, 9, 687–693.
Clark, A. L., Sparrow, J. L., & Coats, A. J. (1995). Muscle fatigue and dyspnoea in chronic heart failure: two sides of the same coin? European Heart Journal, 16, 49–52.
Friedman, M. M. (1997). Older adults’ symptoms and their duration before hospitalization for heart failure. Heart and Lung, 26, 169–176.
Schiff, G. D., Fung, S., Speroff, T., & McNutt, R. A. (2003). Decompensated heart failure: symptoms, patterns of onset, and contributing factors. American Journal of Medicine, 114, 625–630.
Chaudhry, S. I., Wang, Y., Concato, J., Gill, T. M., & Krumholz, H. M. (2007). Patterns of weight change preceding hospitalization for heart failure. Circulation, 116, 1549–1554.
Whellan, D. J., Ousdigian, K. T., Al-Khatib, S. M., Pu, W., Sarkar, S., Porter, C. B., Pavri, B. B., O’Connor, C. M., & PARTNERS Study Investigators. (2010). Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. Journal of the American College of Cardiology, 55, 1803–1810.
Gula, L. J., Wells, G. A., Yee, R., Koehler, J., Sarkar, S., Sharma, V., Skanes, A. C., Sapp, J. L., Redfearn, D. P., Manlucu, J., & Tang, A. S. (2014). A novel algorithm to assess risk of heart failure exacerbation using ICD diagnostics: validation from RAFT. Heart Rhythm, 11, 1626–1631.
Auricchio, A., Gold, M. R., Brugada, J., Nölker, G., Arunasalam, S., Leclercq, C., Defaye, P., Calò, L., Baumann, O., & Leyva, F. (2014). Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: results of the Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT device Trial (CLEPSYDRA) study. European Journal of Heart Failure, 16, 663–670.
Funding sources
None.
Conflict of interest
M. Lovecchio, U. Riva, and S. Valsecchi are employees of Boston Scientific. GB. Forleo, A. Natale, and L. Santini received speaker honoraria from Boston Scientific. The remaining authors have no disclosures.
Author information
Authors and Affiliations
Corresponding author
Additional information
Clinical trial registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT01501331
Appendix
Appendix
The following Italian institutions and investigators participated in the study—Policllinico Tor Vergata, Rome: GB. Forleo, G. Magliano, G. Panattoni, V. Ribatti, D. Sergi, L. Santini, and F. Romeo; Ospedale Belcolle, Viterbo: M. Campoli, M. Malavasi, and M. Sassara; Ospedale SS. Trinità, Sora: A. Scaccia; Ospedale F. Spaziani, Frosinone: L. Carbonardi and M. Menichelli; Ospedale S. Eugenio, Roma: F. Lamberti; Ospedale Santa Maria, Terni: C. Marini and G. Carreras; and Ospedale San Camillo de Lellis, Rieti: S. Orazi and A. Menè.
Rights and permissions
About this article
Cite this article
Forleo, G.B., Santini, L., Campoli, M. et al. Long-term monitoring of respiratory rate in patients with heart failure: the Multiparametric Heart Failure Evaluation in Implantable Cardioverter-Defibrillator Patients (MULTITUDE-HF) study. J Interv Card Electrophysiol 43, 135–144 (2015). https://doi.org/10.1007/s10840-015-0007-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-015-0007-3